MHC haplotypes affect the expression of opportunistic infections in HIV patients

Hum Immunol. 2001 Feb;62(2):157-64. doi: 10.1016/s0198-8859(00)00239-1.

Abstract

This study explores whether MHC genes affect manifestations of opportunistic infections in HIV patients not treated with highly active antiretroviral therapy (HAART) and immunopathologic responses to pre-existing infections in patients who achieved immune reconstitution following HAART (i.e., "immune restoration diseases" or IRD). HLA-B27 and B17 were relatively rare in all HIV patients, but no HLA-B alleles significantly affected cytomegalovirus (CMV) or Mycobacterium avium complex (MAC) disease in patients who had not received HAART. However coexpression of alleles previously defined as the 44.1 ancestral haplotype (HLA-A2, -B44, and -DR4) was more common in the MAC and CMV patients. After HAART, HLA-B44 and (HLA-A2, -B44, -DR4) were found in 66% and 33%, respectively, of patients who experienced an IRD manifested as CMV retinitis and/or encephalomyelitis. This was confirmed by examination of microsatellite alleles, where the C1_2_5 locus in the class I region was most concordant with the 44.1 haplotype in the patients. HLA-B44 was not associated with IRD initiated by Mycobacterium sp, cutaneous VZV or HSV, or HCV infections, suggesting distinct pathologic mechanisms are responsible. CMV retinitis/encephalomyelitis IRD patients had marginally lower pretreatment CD4 T-cell counts, but indices of immune reconstitution were similar in all groups and independent of HLA-B44.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / genetics
  • AIDS-Related Opportunistic Infections / immunology*
  • Adult
  • Alleles
  • Antiretroviral Therapy, Highly Active
  • Cell Line, Transformed
  • Cohort Studies
  • Colitis / genetics
  • Colitis / immunology
  • Cytomegalovirus Infections / genetics
  • Cytomegalovirus Infections / immunology
  • Cytomegalovirus Retinitis / genetics
  • Cytomegalovirus Retinitis / immunology
  • Drug Administration Schedule
  • Encephalomyelitis / genetics
  • Encephalomyelitis / immunology
  • HIV Infections / drug therapy
  • HIV Infections / genetics
  • HIV Infections / immunology
  • HLA-B Antigens / genetics
  • HLA-B44 Antigen
  • HLA-B8 Antigen / genetics
  • Haplotypes / immunology*
  • Humans
  • Major Histocompatibility Complex / genetics*
  • Microsatellite Repeats
  • Mycobacterium avium-intracellulare Infection / genetics
  • Mycobacterium avium-intracellulare Infection / immunology
  • Pilot Projects

Substances

  • HLA-B Antigens
  • HLA-B44 Antigen
  • HLA-B8 Antigen